| Product Code: ETC6738611 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China CAR-T Cell Therapy Treatment Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China CAR-T Cell Therapy Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 China CAR-T Cell Therapy Treatment Market - Industry Life Cycle |
3.4 China CAR-T Cell Therapy Treatment Market - Porter's Five Forces |
3.5 China CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 China CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Structure, 2021 & 2031F |
3.7 China CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Targeted Antigens, 2021 & 2031F |
3.8 China CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Brand, 2021 & 2031F |
3.9 China CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Therapeutic Application, 2021 & 2031F |
4 China CAR-T Cell Therapy Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in China |
4.2.2 Growing investments in healthcare infrastructure and research and development |
4.2.3 Favorable government initiatives and policies supporting cell therapy market in China |
4.3 Market Restraints |
4.3.1 High cost associated with car-t cell therapy treatment |
4.3.2 Limited awareness and adoption of advanced cell therapies |
4.3.3 Regulatory challenges and approvals for new therapies in China |
5 China CAR-T Cell Therapy Treatment Market Trends |
6 China CAR-T Cell Therapy Treatment Market, By Types |
6.1 China CAR-T Cell Therapy Treatment Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 China CAR-T Cell Therapy Treatment Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 China CAR-T Cell Therapy Treatment Market Revenues & Volume, By Autologous CAR-T Cells, 2021- 2031F |
6.1.4 China CAR-T Cell Therapy Treatment Market Revenues & Volume, By Allogeneic CAR-T Cells, 2021- 2031F |
6.2 China CAR-T Cell Therapy Treatment Market, By Structure |
6.2.1 Overview and Analysis |
6.2.2 China CAR-T Cell Therapy Treatment Market Revenues & Volume, By First Generation CAR-T Cells, 2021- 2031F |
6.2.3 China CAR-T Cell Therapy Treatment Market Revenues & Volume, By Second Generation Car-T Cells, 2021- 2031F |
6.2.4 China CAR-T Cell Therapy Treatment Market Revenues & Volume, By Third Generation CAR-T Cells, 2021- 2031F |
6.2.5 China CAR-T Cell Therapy Treatment Market Revenues & Volume, By Fourth Generation CAR-T Cells, 2021- 2031F |
6.3 China CAR-T Cell Therapy Treatment Market, By Targeted Antigens |
6.3.1 Overview and Analysis |
6.3.2 China CAR-T Cell Therapy Treatment Market Revenues & Volume, By Antigens on Solid Tumors, 2021- 2031F |
6.3.3 China CAR-T Cell Therapy Treatment Market Revenues & Volume, By Antigens on Hematologic Malignancies, 2021- 2031F |
6.4 China CAR-T Cell Therapy Treatment Market, By Brand |
6.4.1 Overview and Analysis |
6.4.2 China CAR-T Cell Therapy Treatment Market Revenues & Volume, By Yescarta, 2021- 2031F |
6.4.3 China CAR-T Cell Therapy Treatment Market Revenues & Volume, By Kymriah, 2021- 2031F |
6.4.4 China CAR-T Cell Therapy Treatment Market Revenues & Volume, By Tecartus, 2021- 2031F |
6.5 China CAR-T Cell Therapy Treatment Market, By Therapeutic Application |
6.5.1 Overview and Analysis |
6.5.2 China CAR-T Cell Therapy Treatment Market Revenues & Volume, By Hematological Malignancies, 2021- 2031F |
6.5.3 China CAR-T Cell Therapy Treatment Market Revenues & Volume, By Pancreatic Cancer, 2021- 2031F |
6.5.4 China CAR-T Cell Therapy Treatment Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.5.5 China CAR-T Cell Therapy Treatment Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.5.6 China CAR-T Cell Therapy Treatment Market Revenues & Volume, By Gastric Cancer, 2021- 2031F |
6.5.7 China CAR-T Cell Therapy Treatment Market Revenues & Volume, By Multiple Myeloma, 2021- 2031F |
7 China CAR-T Cell Therapy Treatment Market Import-Export Trade Statistics |
7.1 China CAR-T Cell Therapy Treatment Market Export to Major Countries |
7.2 China CAR-T Cell Therapy Treatment Market Imports from Major Countries |
8 China CAR-T Cell Therapy Treatment Market Key Performance Indicators |
8.1 Number of clinical trials and research studies conducted in the field of car-t cell therapy in China |
8.2 Patient enrollment rates for car-t cell therapy treatments |
8.3 Success rates and efficacy of car-t cell therapy treatments in clinical settings |
8.4 Number of partnerships and collaborations between key stakeholders in the car-t cell therapy market in China. |
9 China CAR-T Cell Therapy Treatment Market - Opportunity Assessment |
9.1 China CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 China CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Structure, 2021 & 2031F |
9.3 China CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Targeted Antigens, 2021 & 2031F |
9.4 China CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Brand, 2021 & 2031F |
9.5 China CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Therapeutic Application, 2021 & 2031F |
10 China CAR-T Cell Therapy Treatment Market - Competitive Landscape |
10.1 China CAR-T Cell Therapy Treatment Market Revenue Share, By Companies, 2024 |
10.2 China CAR-T Cell Therapy Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here